A detailed history of Bahl & Gaynor Inc transactions in Cvs Health Corp stock. As of the latest transaction made, Bahl & Gaynor Inc holds 17,105 shares of CVS stock, worth $964,550. This represents 0.01% of its overall portfolio holdings.

Number of Shares
17,105
Previous 15,833 8.03%
Holding current value
$964,550
Previous $1.26 Million 19.97%
% of portfolio
0.01%
Previous 0.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

BUY
$53.63 - $79.56 $68,217 - $101,200
1,272 Added 8.03%
17,105 $1.01 Million
Q1 2024

May 10, 2024

BUY
$71.99 - $81.42 $120,943 - $136,785
1,680 Added 11.87%
15,833 $1.26 Million
Q4 2023

Feb 02, 2024

SELL
$66.29 - $79.0 $21,212 - $25,280
-320 Reduced 2.21%
14,153 $1.12 Million
Q3 2023

Nov 03, 2023

SELL
$65.17 - $76.41 $55,133 - $64,642
-846 Reduced 5.52%
14,473 $1.01 Million
Q2 2023

Aug 14, 2023

SELL
$66.65 - $77.75 $220,078 - $256,730
-3,302 Reduced 17.73%
15,319 $1.06 Million
Q1 2023

May 03, 2023

BUY
$72.37 - $92.89 $689,975 - $885,613
9,534 Added 104.92%
18,621 $1.38 Million
Q4 2022

Feb 10, 2023

BUY
$88.25 - $103.78 $313,111 - $368,211
3,548 Added 64.05%
9,087 $846,000
Q2 2022

Aug 08, 2022

BUY
$88.66 - $106.64 $12,323 - $14,822
139 Added 2.57%
5,539 $513,000
Q1 2022

May 12, 2022

SELL
$100.77 - $110.83 $11,084 - $12,191
-110 Reduced 2.0%
5,400 $547,000
Q4 2021

Feb 10, 2022

SELL
$83.15 - $103.7 $18,708 - $23,332
-225 Reduced 3.92%
5,510 $568,000
Q2 2021

Aug 06, 2021

SELL
$73.79 - $89.81 $83,751 - $101,934
-1,135 Reduced 16.52%
5,735 $479,000
Q1 2021

May 11, 2021

BUY
$68.13 - $76.3 $29,636 - $33,190
435 Added 6.76%
6,870 $517,000
Q4 2020

Feb 02, 2021

BUY
$55.93 - $74.5 $95,081 - $126,650
1,700 Added 35.9%
6,435 $440,000
Q3 2020

Nov 12, 2020

SELL
$56.71 - $65.71 $18,487 - $21,421
-326 Reduced 6.44%
4,735 $277,000
Q2 2020

Aug 13, 2020

BUY
$55.41 - $70.62 $20,280 - $25,846
366 Added 7.8%
5,061 $329,000
Q1 2020

May 26, 2020

BUY
$52.3 - $76.05 $245,548 - $357,054
4,695 New
4,695 $279,000
Q1 2020

May 15, 2020

SELL
$52.3 - $76.05 $282,890 - $411,354
-5,409 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$60.38 - $76.58 $47,579 - $60,345
-788 Reduced 12.72%
5,409 $402,000
Q3 2019

Nov 14, 2019

SELL
$54.09 - $64.3 $28,505 - $33,886
-527 Reduced 7.84%
6,197 $391,000
Q2 2019

Aug 12, 2019

SELL
$52.13 - $57.33 $333,527 - $366,797
-6,398 Reduced 48.76%
6,724 $366,000
Q1 2019

May 13, 2019

SELL
$52.36 - $69.88 $90,111 - $120,263
-1,721 Reduced 11.59%
13,122 $708,000
Q4 2018

Feb 12, 2019

SELL
$62.92 - $80.8 $76,447 - $98,172
-1,215 Reduced 7.57%
14,843 $973,000
Q3 2018

Nov 09, 2018

SELL
$63.78 - $79.59 $56,381 - $70,357
-884 Reduced 5.22%
16,058 $1.26 Million
Q2 2018

Aug 14, 2018

SELL
$60.71 - $72.18 $222,866 - $264,972
-3,671 Reduced 17.81%
16,942 $1.09 Million
Q1 2018

May 11, 2018

BUY
$60.6 - $83.63 $65,145 - $89,902
1,075 Added 5.5%
20,613 $1.28 Million
Q4 2017

Feb 13, 2018

BUY
$66.8 - $80.91 $357,112 - $432,544
5,346 Added 37.67%
19,538 $1.42 Million
Q3 2017

Nov 13, 2017

SELL
$75.35 - $83.31 $18,837 - $20,827
-250 Reduced 1.73%
14,192 $1.15 Million
Q2 2017

Aug 11, 2017

SELL
N/A
-313 Reduced 2.12%
14,442 $1.16 Million
Q2 2017

Aug 10, 2017

BUY
N/A
14,755
14,755 $1.17 Million

Others Institutions Holding CVS

About CVS HEALTH Corp


  • Ticker CVS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Healthcare Plans
  • Shares Outstandng 1,312,829,952
  • Market Cap $74B
  • Description
  • CVS Health Corporation provides health services in the United States. The company's Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governme...
More about CVS
Track This Portfolio

Track Bahl & Gaynor Inc Portfolio

Follow Bahl & Gaynor Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bahl & Gaynor Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bahl & Gaynor Inc with notifications on news.